Giant Angiolymphoid Hyperplasia with Eosinophilia on the Chest by Trindade, F et al.
J Cutan Pathol 2009: 36: 493–496
doi: 10.1111/j.1600-0560.2008.01066.x
Blackwell Munksgaard. Printed in Singapore
Copyright # 2008 Blackwell Munksgaard
Journal of
Cutaneous Pathology
Giant angiolymphoid hyperplasia with
eosinophilia on the chest
Angiolymphoid hyperplasia with eosinophilia is a rare vascular
proliferation characterized by single or multiple purplish, brownish
papules and subcutaneous nodules, sometimes associated with pain or
pruritus. This rare benign process occurs with a female predominance.
Approximately 85% of the lesions occur in the skin of the head and
neck; most of them are around the ear or on the forehead or scalp.
Whether angiolymphoid hyperplasia with eosinophilia represents
a benign neoplasm or an unusual reaction to varied stimuli, including
trauma, the etiology remains unclear. Histopathologically, the lesions
consist of a proliferation of blood vessels of variable size lined by large
epithelioid endothelial cells and a variable inflammatory infiltrate of
lymphocytes and eosinophils, sometimes with lymphoid follicle
formation. The lesion is benign but may be persistent and is difficult to
eradicate. We report on a case of a 58-year-old Caucasian man who
presented a purplish pink dome-shaped tumor of size up to 8 cm in
diameter located on the chest. We emphasize this case considering the
unusual dimensions of the lesion (8 cm diameter) and the atypical
location on the chest.
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The term histiocytoid hemangioma’, initially coined
by Rosai et al.,1 embraced several cutaneous and
extracutaneous vascular proliferations, both benign
and malignant, characterized by the proliferation of
histiocytoid endothelial cells.
Angiolymphoid hyperplasia with eosinophilia was
originally described by Wells and Whimster2 in 1969
as subcutaneous angiolymphoid hyperplasia with
eosinophilia’. They first linked this disorder to
Kimura’s disease because they considered angiolym-
phoid hyperplasia with eosinophilia as a late stage of
Kimura’s disease. The rare occurrence of Kimura’s
disease in White patients caused the confusion
between Kimura’s disease and angiolymphoid hyper-
plasia with eosinophilia.3 Rosai et al.1 were the first to
note that Kimura’s disease and angiolymphoid
hyperplasia with eosinophilia are actually two differ-
ent clinicopathological entities.
Because of its historical denomination and its
reactive nature, probably as a consequence of an
arteriovenous shunt, angiolymphoid hyperplasia with
eosinophilia is included within the group of vascular
hyperplasias.4
It has been described with different names by
different authors, including atypical pyogenic granu-
loma,5 pseudopyogenic granuloma,6 inflammatory
angiomatous nodule,6 inflammatory arteriovenous
hemangioma,7 papular angioplasia,8 intravenous
atypical vascular proliferation,9 epithelioid hemangi-
oma10 and cutaneous histiocytoid hemangioma.1
We report on a large solitary lesion of angiolym-
phoid hyperplasia with eosinophilia involving the
chest. The location and the large size of the lesion
were the two most striking characteristics of this case.
Case report
A 58-year-old Caucasian man presented with a tumor
located in the thorax. The lesion arose during the past
6 months and had always been asymptomatic.
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Physical examination revealed a purplish pink
dome-shaped tumor of size up to 8 cm in diameter
(Fig. 1). The tumor was surrounded by a peripheral
hyperpigmented brownish halo, which showed a size
of 12 cm in diameter.
Routine blood tests including peripheral eosinophil
count revealed normal results.
The lesion was surgically removed, and histological
examination showed a prominent proliferation of
blood vessels with variable size and shape involving
the full thickness of the dermis. The thickness of the
vessel walls was also variable, but a common finding
consisted of plump endothelial cells lining the vascular
lumina (Fig. 2). Some of the endothelial cells showed
cytoplasmic vacuoles as expression of primitive
vascular differentiation. Around the vessels, there
was fibrillary fibroplasia and an inflammatory
infiltrate with abundant number of lymphocytes and
eosinophils (Fig. 3). At the periphery, which corre-
sponded clinically with the peripheral macular brown
halo, the lesion was composed mostly by a pro-
liferation of small thin-walled capillary blood vessels
with abundant deposits of hemosiderin in the stroma.
A diagnosis of angiolymphoid hyperplasia with
eosinophilia was established.
At the 3-months follow up, therewas no evidence of
tumor recurrence or metastatic disease.
Discussion
Angiolymphoid hyperplasiawith eosinophilia is a rare
benign vascular proliferation that manifests in adults
as solitary or multiple purplish, brownish papules,
plaques or nodules. It has different presentations
resulting in various clinical impressions. In a study of
116 patients by Olsen and Helwig,11 the most
common clinical diagnoses were epidermal cysts
and hemangiomas.
The lesions occur in the head and neck; most of
them are on or near the periauricular region,
forehead or scalp.11 Rare sites of involvement include
the hands, shoulders, breasts, penis, vulva and oral
mucosa.11–15 It has also been described in other
tissues, including liver, orbit, spleen, palate, bone,
heart and blood vessels. It is associated with
peripheral blood eosinophilia of 6–34% in about
20% of patients.11
Approximately 80% of patients present with
isolated lesions, while the remaining patients usually
show grouped papules or nodules in a single region.16
They are often pruritic or painful and may coalesce
into confluent chronic plaques, with little propensity
for spontaneous resolution.11
Most intradermal lesions are small, with diameters
of 0.5–2 cm, with a range of 0.2–8 cm. Larger
nodules tend to be deeply situated within the subcutis,
up to 5–10 cm in diameter.11
Angiolymphoid hyperplasia with eosinophilia is
seen most commonly in Asians followed by White
Fig. 1. Clinical appearance of the tumor located in the thorax size
up to 8 cm in diameter.
Fig. 2. Scanning power showing the histopathological features of
angiolymphoid hyperplasia with eosinophilia. Thick-walled blood
vessels with protuberant endothelium and a prominent inflammatory
infiltrate composed of lymphocytes and eosinophils (hematoxylin-
eosin stain; original magnification 310).
Fig. 3. Higher magnification showing the histopathological charac-
teristics of the vessels surrounded by a perivascular and interstitial
inflammatory infiltrate mostly composed of lymphocytes and
eosinophils (hematoxylin-eosin stain; original magnification 3200).
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people. It is slightly more common in females16 and
usually present in patients aged 20–50 years, with
meanonset of 30–33 years. The lesions can persist but
serious complications (e.g. malignant transformation)
do not occur.17
The origin of the disease is not known; numerous
factors suggest that it is an unusual reactive process.
Infection (human T lymphotropic virus or human
herpesvirus 8), hormonal background or possible role
of trauma is the mostly discussed possibilities.
Increased expression of vascular endothelial growth
factor and interleukin 5 was detected in some cases.18
When the biopsy incision is large and sufficiently
deep, an arteriovenous shunt is found in a significant
percentage of the cases.19 These features suggest that
angiolymphoid hyperplasia with eosinophilia is not
neoplastic in nature, but arises from a reactive
hyperplastic process probably as a result of damage
and repair of an artery or vein.10
Higher prevalence of the disease among women
and occurrence of the disease in association with sex
hormones are two important observations supporting
that sex hormonesmay play a role in the pathogenesis
of angiolymphoid hyperplasia with eosinophilia.19
Kimura’s disease was earlier thought to be related
to angiolymphoid hyperplasia with eosinophilia, but
nowadays, it is considered a different clinical entity.3
The disorder was originally described by Kimura
et al. in 1948 as an unusual granulation combined
with hyperplastic changes of lymphatic tissue’.20
In particular, Kimura’s disease predominantly
affects young males of Asian descent.21 This disorder
is frequently accompanied by enlarged regional
lymph nodes with or without an associated soft tissue
mass, high incidence of peripheral blood eosinophilia
and elevated serum immunoglobulin E levels.3
Angiolymphoid hyperplasia with eosinophilia
shows characteristic histopathological features,
including a proliferation of irregular thick-walled
blood vessels, many of which lined by enlarged
endothelial cells with uniform ovoid nuclei and
intracytoplasmic vacuoles.17 Walls of the aberrant
vessels often have smooth muscle and abundant
mucin. Endothelial proliferative cells with epithelioid
appearance may also appear as solid aggregations
disposed in sheets, and the angiomatous nature of the
lesion is less evident.4 These plump endothelial cells
are characteristic of this condition, and they have
been named by different authors as histiocytoid,
epithelioid or hobnail endothelial cells.4 The hobnail
cells protrude prominently into the lumina of the
vessels, and intravascular proliferation of them may
be seen in the lumina of larger vessels. In addition,
a perivascular and interstitial infiltrate composed
primarily of lymphocytes and eosinophils is present.
Eosinophils typically comprise 5–15% of the infiltrate.
Rarely, they can account for as much as 50% of the
infiltrate.17 Occasionally, the infiltrate is devoid of
eosinophils. In some cases, lymphoid follicles with
germinal centers are present, but usually, they are not
as prominent as in Kimura’s disease.4 Endothelial
cells are positive for factor VIII-related antigen,10
Ulex europaeus I lectin,14 CD34,22 CD3122 and
vimentin.22 Ultrastructural studies showed Weibel-
Palade bodies in the endothelial cells.22
Lesions of angiolymphoid hyperplasia with eosin-
ophilia can remit over the course of months or years,
but they tend to persist or recur. There is no
consistently effective treatment for this disease. Intra-
lesional corticosteroids and irradiation are among the
modalities used. Other treatments that have been
reported include topical imiquimod, topical tacroli-
mus and interferon alfa-2b.17,23 Although surgical
excision can be curative, recurrences are common.
Deep surgical excision that includes the arterial and
venous segments at the base of the lesion has been
reported to have the most favorable results, with no
reported recurrence after 1-year follow up.23
Destructive techniques such as cryotherapy and
electrodessication may be attempted. In addition,
pulsed dye lasers have been used to selectively target
the vasculoproliferative component of this disorder.24
Multiple laser treatments are generally necessary to
cause resolution.The use of a long-pulse turntable dye
laser has been advocated based on its deeper pene-
tration and greater epidermal sparing properties.
We emphasize this case considering the unusual
dimensions of the tumor (8 cm diameter) and the
atypical location on the chest.
References
1. Rosai J, Gold J, Landy R. The histiocytoid hemangiomas:
a unifying concept embracing several previously described
entities of skin, soft tissue, large vessels, bone, and heart. Hum
Pathol 1979; 10: 707.
2. Wells GC, Whimster IW. Subcutaneous angiolymphoid hyper-
plasia with eosinophilia. Br J Dermatol 1969; 81: 1.
3. Requena L, Sangueza OP. Cutaneous vascular proliferations.
Part III. Malignant neoplasms, other cutaneous neoplasms with
significant vascular component, and disorders erroneously
considered as vascular neoplasms. J Am Acad Dermatol
1998; 38: 143.
4. Requena L, Sangueza OP. Cutaneous vascular proliferations.
Part II. Hyperplasias and benign neoplasms. J Am Acad
Dermatol 1997; 37: 887.
5. Peterson WC, Fusaro RM, Goltz RW. Atypical pyogenic
granuloma: a case of benign hemangioendotheliomatosis. Arch
Dermatol 1964; 90: 197.
6. Wilson Jones E, Bleehen SS. Inflammatory angiomatous
nodules with abnormal blood vessels occurring about the ears
and scalp (pseudo- or atypical pyogenic granuloma). Br J
Dermatol 1969; 81: 804.
7. Girard C, Graham JH, Johnson WC. Arteriovenous hemangi-
oma (arteriovenous shunt): a clinicopathological and histo-
chemical study. J Cutan Pathol 1974; 1: 73.
Giant angiolymphoid hyperplasia
495
8. Jones E, Marks R. Papular angioplasia: vascular papules of the
face and scalp simulating malignant vascular tumors. Arch
Dermatol 1970; 102: 422.
9. Rosai J, Ackerman LR. Intravenous atypical vascular pro-
liferation: a cutaneous lesion simulating a malignant blood
vessel tumor. Arch Dermatol 1974; 109: 714.
10. Fetsch JF, Weiss SW. Observations concerning the pathogenesis
of epithelioid hemangioma (angiolymphoid hyperplasia). Mod
Pathol 1991; 4: 449.
11. Olsen TG, Helwig EB. Angiolymphoid hyperplasia with
eosinophilia: a clinicopathologic study of 116 patients. J Am
Acad Dermatol 1985; 12: 781.
12. Castro C, Winkelmann RK. Angiolymphoid hyperplasia with
eosinophilia in the skin. Cancer 1974; 34: 1696.
13. Aguilar A, Ambrojo P, Requena L, Olmos L, Sanchez Yus E.
Angiolymphoid hyperplasia with eosinophilia limited to the
vulva. Clin Exp Dermatol 1990; 15: 65.
14. Srigley JR, Ayala AG, Ordon˜ez NG, et al. Epithelioid
hemangioma of the penis: a rare and distinctive vascular
lesion. Arch Pathol Lab Med 1985; 109: 51.
15. Masa FC, Fretzin DF, Chowdhury L, et al. Angiolymphoid
hyperplasia demonstrating extensive skin and mucosal lesions
controlled with vinblastine therapy. J Am Acad Dermatol 1984;
11: 333.
16. Weiss SW, Goldblum JR. Benign tumors and tumor-like lesions
of blood vessels. In Enzinger FM, Weiss SW, eds. Soft tissue
tumors. 4th ed. Philadelphia, PA: CV Mosby Co, 2001; 856.
17. Glusac E. Angiolymphoid hyperplasia with eosinophilia. eMedi-
cine 2002. URL http://www.emedicine.com/derm/topic30.
htm [accessed on 28 January 2004].
18. Aoki M, Kimura Y. Angiolymphoid hyperplasia with eosino-
philia associated with anomaluos dilatation of occipital artery:
iL-5 and VEGF expression of lesional mast cells. Arch Dermatol
2002; 138: 982.
19. Zarrin-Kameh N, Spoden JE, Tran RM. Angiolymphoid hyper-
plasia with eosinophilia associated with pregnancy: a case report
and review of the literature. Arch Pathol LabMed 2005; 129: 1168.
20. Kimura T, Yoshimura S, Ishikama E. On the unusual
granulation combined with hyperplastic changes of lymphatic
tissues. Trans Soc Pathol Jpn 1948; 37: 178.
21. Kung ITM, Gibson JB, Bannatyne PM. Kimura’s disease: a
clinicopathological study of 21 cases and its distinction from an-
giolymphoid hyperplasia with eosinophilia. Pathology 1984; 16: 39.
22. Angervall L, Kindblom LG, Karlsson K, et al. Atypical
hemangioendothelioma of venous origin: a clinicopathologic
angiographic immunohistochemical and ultrastructural study of
two endothelial tumors within the concept of histiocytoid
hemangioma. Am J Surg Pathol 1985; 9: 504.
23. Baum EW, Sams WM Jr, Monheit GD. Angiolymphoid
hyperplasia with eosinophilia: the disease and a comparison
of treatment modalities. J Dermatol Surg Oncol 1982; 8: 966.
24. Papadavid E, Krausz T, Chu AC, Walker NPJ. Angiolymphoid
hyperplasia with eosinophilia successfully treated with the flash-
lamp pulsed-dye laser. Br J Dermatol 2000; 142: 192.
Trindade et al.
496
